DPP-4 inhibitors and increased reporting odds of bullous pemphigoid: a pharmacovigilance study of the FDA adverse event reporting system (FAERS) from 2006 to 2020
Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al
FDA approval is notoriously thorough, rigorous, and expensive
Semaglutide is the active ingredient used for diabetes and weight loss medications, which include Ozempic, Wegovy, and Rybelsus
A common and easy-to-manage concentration is 10mg of GHK-Cu per 1mL of BAC water
Clinical trial data clearly shows that participants starting at 2 mg experienced significantly fewer GI symptoms than those starting at 4 mg